Risk Overload and Risk Misdirection in the Consent Process Mark Hochhauser, Ph.D. Readability Consultant Golden Valley, Minnesota
|
|
- Hillary Norris
- 5 years ago
- Views:
Transcription
1 Risk Overload and Risk Misdirection in the Consent Process Mark Hochhauser, Ph.D. Readability Consultant Golden Valley, Minnesota Understanding risks is a key part of the informed consent process for prospective subjects. If they don't understand the trial's risks they can't make informed decisions about whether to participate in the trial or not. For example, research organizations typically explain to prospective subjects how important it is for them to understand clinical trial risks (italics added): 1) "Informed consent is the process of ensuring that people understand all of the benefits and risks involved in a clinical trial before deciding whether or not to participate." 2) "Before you agree to join a clinical trial, researchers must be sure that you understand everything about the study - risks, benefits, obligations, etc." 3) "All subjects in clinical trials must give informed consent, which is a process that helps provide full and complete understanding of the risks and benefits of the study before and after research participation begins." Can anyone understand 160 risks? As desirable as it is for prospective subjects to understand all of a trial's risks, can they realistically achieve "complete understanding?" Clinical trials involving drug combinations are complicated, with long and detailed risk descriptions. Based on four clinical trials that came to our IRB, I counted the risks for each trial. Because I chose to count as one risk those risks that were separated by a comma, semi-colon or colon, the total risks might have been even higher using a different counting strategy. For example: Is "nausea and/or vomiting" one risk or two? Is "skin ulcer, hives or welts" one risk or three? Is "loss of energy or fatigue" one risk or two? Trial #1 had four drug combinations, Drug A had 26 risks, Drug B had 34, Drug C had 45 and Drug D had 50 = 155 risks. Trial #2 used six drugs: Drug A had 42, Drug B had 36, Drug C had 18, Drug D had 20, Drug E had 19 and Drug F had 27 = 160 risks. Trial #3 used three drugs: Drug A had 31 risks, Drug B had 17 and C had 34 = 82 risks. Trial #4 used 3 drugs: Drug A had 21 side effects, Drug B had 10 "important" side effects and Drug C had 43 side effects = 74 side effects. Signing "I understand " In the signature section of all three trials, prospective subjects signed under the sentence "I have read this consent form and understand the possible risks and benefits of my participation in this study." While agreement with that statement may make subjects, researchers and sponsors believe that subjects actually do understand the possible risks of the study, it's unlikely that subjects could remember many of the risks or their likelihood, severity or importance if later asked. Incomprehensible Risk Categories Risk categories present another problem. That is, it's one thing to count the number of risks, it's another to place trial risks into meaningful risk categories. Table #1 shows the risk categories for these four clinical trials. 1
2 Risk categories in Table #1 aren't helpful because there's no standardization of risk language; #1) likelihood, #2) frequency and commonness, #3) severity + commonness, #4) mixed frequency and importance will have different meanings for different researchers and subjects. Plus, it's not clear if "risks" and "side effects" have the same meaning for prospective subjects; are "side effects" less dangerous than "risks?" Trial #1 categorized risks as likely, less likely, but serious, and rare, but those terms are meaningless without some kind of quantitative explanation how "likely" is "likely?" Trial #2 tries to be quantitative but without much success. Not all subjects know that < and > means "less than" and "greater than." Trial #3 combines severity and commonness in categories that can only be described as incomprehensible. Trial #4 used a good combination of quantitative and quality risks for two of the drugs, but the third drug included 10 "important side effects" with no quantitative or qualitative descriptors. How can subjects be expected to "completely understand" 74 to 160 risks in categories that aren't of much help? Ideally, risks should be described as the percentage of subjects who might experience those risks as done in Trial #4 for two of the three drugs. Unfortunately, such data isn't always available for the experimental drugs being tested, although sponsors may have that kind of data from similar drugs already studied or approved by the FDA. Risk Misdirection A recent United Kingdom study 1 looked at people's risk perceptions for a hypothetical clinical trial by giving them either a verbal risk description (common, uncommon, rare) or a combined risk description (common = 1% - 19%; uncommon =.1% - 1%; rare 0.1% -.1%) based on European Union (EU) guidelines. As shown in Table #2, subjects given only the verbal risk description rated their likelihood of experiencing a risk 3 times higher than those receiving a combined risk description. Note that even those who were given the actual EU risk description still overestimated the likelihood that they would experience risks! That is, even though they were told that a common risk would affect 1% - 10% of subjects, they believed that their likelihood of experiencing a common risk would be 19%. These undefined Verbal Risk Descriptions create risk misdirection in which subjects perceive risks to be more common than they actually are. Compared to those getting the Combined Risk Description, those getting Verbal Risk Description were more likely to perceive the study as having a risk to health, but were less likely to be satisfied with the information, saw less possible benefit to their health, and had less intent to participate, listing "lack of adequate information" as a reason for not participating in the trial. Combining risk overload with ambiguous risk categories means that prospective subjects will overestimate clinical trial risks which may cause them to decide not to participate in that trial. More accurate portrayal of clinical trial risks isn't just an informed consent communication issue, but a recruiting issue. If you're having a hard time recruiting subjects, perhaps it is because subjects perceive more risks in the clinical trial than actually exist. Reference: 2
3 1. Berry, D.C. and Hochhauser, M. (2006) Verbal Labels Can Triple Perceived Risks in Clinical Trials. Drug Information Journal, 40(3),
4 Table #1: Risk categories in four clinical trials Trial #1 Likely Less likely, but serious Trial #2 Most frequent Frequent (>50%); (20-50%); Most common Less common Trial #3 Trial #4 Most serious; Very common up to 1 in 10 Likely 50% or more Very common; Severe in more than 1 in 10 Frequent 10% - 50% Rare N/A N/A Sometimes (>5 and <20%); Rare Less common: Severe in up to 1 in 10 Occasional 1-10% Seldom (less than or equal to 5%) Very common: Not severe in more than 1 in 10 Rare Less than 1% N/A Uncommon; Up to 1 in 100 of any severity Important Side Effects 4
5 Table #2: Risk estimates based on verbal and combined risk descriptions European Union Risk Description Verbal Risk Description Combined Risk Description (Verbal + EU Description Common (1% - 10%) 58% 19% Uncommon (0.1% - 1%) 23% 7% Rare (.01% -.1%) 12% 4% 5
" in language understandable to the subject "--or not. Mark Hochhauser, Ph.D. Readability Consultant Golden Valley, Minnesota
" in language understandable to the subject "--or not. Mark Hochhauser, Ph.D. Readability Consultant Golden Valley, Minnesota In its 1995 Information Sheets for Institutional Review Boards and Clinical
More informationPROSTATE CANCER SCREENING SHARED DECISION MAKING VIDEO
PROSTATE CANCER SCREENING SHARED DECISION MAKING VIDEO 1 00:00:00,067 --> 00:00:10,968 2 00:00:10,968 --> 00:00:12,701 So, you were given a decision aid sheet 3 00:00:12,701 --> 00:00:14,567 about prostate
More informationI nforming people effectively about the risk of side effects
176 ORIGINAL ARTICLE Comparison of two methods of presenting risk information to patients about the side effects of medicines P Knapp, D K Raynor, D C Berry... See editorial commentary, p 169 See end of
More informationFactors influencing the perception of side effect risk information
School of Psychology FACULTY OF MEDICINE AND HEALTH Patient Information Forum Communicating risk in health information 26 th January 2016, London Factors influencing the perception of side effect risk
More informationClinical Research Ethics Question of the Month: Social Media Activity
Vol. 14, No. 4, April 2018 Happy Trials to You Clinical Research Ethics Question of the Month: Social Media Activity By Norman M. Goldfarb You are the chairperson of an IRB overseeing a study comparing
More informationRecording Transcript Wendy Down Shift #9 Practice Time August 2018
Recording Transcript Wendy Down Shift #9 Practice Time August 2018 Hi there. This is Wendy Down and this recording is Shift #9 in our 6 month coaching program. [Excuse that I referred to this in the recording
More informationExploring YOUR inner-self through Vocal Profiling
Exploring YOUR inner-self through Vocal Profiling Thank you for taking the opportunity to experience the BioVoice computer program. As you speak into the microphone, the computer will catalog your words
More informationJuly Introduction
Case Plan Goals: The Bridge Between Discovering Diminished Caregiver Protective Capacities and Measuring Enhancement of Caregiver Protective Capacities Introduction July 2010 The Adoption and Safe Families
More informationUNIVERSITY OF WISCONSIN-MADISON Research Participant Information and Consent Form
UNIVERSITY OF WISCONSIN-MADISON Research Participant Information and Consent Form Title of the Study: Grammatical Development in Boys with Fragile X Syndrome and Autism Principal Investigator: Audra Sterling,
More informationNational NHS patient survey programme Survey of people who use community mental health services 2014
National NHS patient survey programme Survey of people who use community mental health services The Care Quality Commission The Care Quality Commission (CQC) is the independent regulator of health and
More informationMaking An Exercise Plan
Making An Exercise Plan The purpose of an Exercise Rx (prescription) is to provide a guide for your workouts that 1. is specifically designed to help you meet your fitness goals, 2. is controlled by how
More informationThe! Lie Detection Cheat Sheet!
The Lie Detection Cheat Sheet By Paul Mascetta Welcome to the The Lie Detection Cheat Sheet. I realize this can be a touchy or even controversial topic. Listen, I m a firm believer in the power of positive
More information/index.php/better-language-teaching /index.php/grammar-worksheets the ARTICLE (for teachers) If you live in or visit Japan, you may be asked, "What's your blood type?" When the average person asks the
More informationEvaluating you relationships
Evaluating you relationships What relationships are important to you? What are you doing today to care for them? Have you told those concerned how you feel? Most of us regularly inspect the health of our
More informationPage 1 of 6 More Log increate an Account April 26, 2012 Edition: U.S. CA Canada Québec FR France US United States UK United Kingdom 18k Page 2 of 6 Follow chronic conditions, Cancer, Health Care, Health
More informationBest Practice Model Communication/Relational Skills in Soliciting the Patient/Family Story Stuart Farber
Best Practice Model Communication/Relational Skills in Soliciting the Patient/Family Story Stuart Farber Once you have set a safe context for the palliative care discussion soliciting the patient's and
More informationNAMI In Our Own Voice Presenter Screening Tool
NAMI In Our Own Voice Presenter Screening Tool This tool has been developed by individuals who are currently involved in recruiting and evaluating consumers for NAMI programs. It is offered as a relevant
More informationPATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM FERRERI / IELSG PROTOCOL. Patient s first names. Date of birth
Page 1 of 6 FORM FERRERI / IELSG PROTOCOL Patient s surname/family name Patient s first names Date of birth Hospital Name: Guy s Hospital St. Thomas Hospital King s College Hospital Lewisham Hospital NHS
More informationChapter 5 Analyzing Quantitative Research Literature
Activity for Chapter 5 Directions: Locate an original report of a quantitative research, preferably on a topic you are reviewing, and answer the following questions. 1. What characteristics of the report
More informationTaking Part in Cancer Treatment Research Studies
Taking Part in Cancer Treatment Research Studies U.S. Department of Health & Human Services National Institutes of Health Taking Part in Cancer Treatment Research Studies If you have cancer, you may want
More informationThe Scientific Method
The Scientific Method Prelab Thoroughly explore the website Understanding Science: How Science Really Works at http://undsci.berkeley.edu. Answer the following five questions based on your textbook and
More informationThe Satisfaction in the doctor-patient relationship: the communication assessment
EUROPEAN ACADEMIC RESEARCH Vol. IV, Issue 2/ May 2016 ISSN 2286-4822 www.euacademic.org Impact Factor: 3.4546 (UIF) DRJI Value: 5.9 (B+) The Satisfaction in the doctor-patient relationship: the LEJDA ABAZI
More informationPEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL)
PEER REVIEW HISTORY BMJ Open publishes all reviews undertaken for accepted manuscripts. Reviewers are asked to complete a checklist review form (http://bmjopen.bmj.com/site/about/resources/checklist.pdf)
More informationBehaviorism: An essential survival tool for practitioners in autism
Behaviorism: An essential survival tool for practitioners in autism What we re going to do today 1. Review the role of radical behaviorism (RB) James M. Johnston, Ph.D., BCBA-D National Autism Conference
More informationPatient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM ABVD. Patient s first names.
Patient identifier/label: Page 1 of 6 Patient s surname/family name Patient s first names Date of birth Hospital Name: Guy s Hospital St. Thomas Hospital King s College Hospital Lewisham Hospital NHS number
More informationPatient identifier/label: Page 1 of 6 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM CYTARABINE (HIGH DOSE)
Patient identifier/label: Page 1 of 6 CYTARABINE Patient s surname/family name Patient s first names Date of birth Hospital Name: Guy s Hospital St. Thomas Hospital King s College Hospital Lewisham Hospital
More informationAssignment 4: True or Quasi-Experiment
Assignment 4: True or Quasi-Experiment Objectives: After completing this assignment, you will be able to Evaluate when you must use an experiment to answer a research question Develop statistical hypotheses
More informationPATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Dabrafenib-Trametinib PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL
More informationDon't think that DD can have anything to do with your joint problems BUT that isn't to say that the way you are walking because of pain in
15-1-2012 Don't think that DD can have anything to do with your joint problems BUT that isn't to say that the way you are walking because of pain in the abdomen can't have a. Symptoms of diverticulitis
More informationDay 3: Day 1: Day 2: You are infected. Visit the medical team. Will you live or die?
is coming! Day 1: starts in one place in the school. Each sufferer can infect up to 4 others. F Day 2: passes from class to class. Your health is in danger. Day 3: You are infected. Visit the medical team.
More informationSUSSEX DOWNS COLLEGE A LEVEL PSYCHOLOGY AQA
This booklet has a variety of A01, A02 and A03 exam questions. Identify which question is which A0 down the side of the q s You should aim to complete at least 3 questions a week, Highlight / tick them
More informationCONSENT FORM. The Full Study Title Should Be Placed Here. Principal Investigator: Dr. John Smith Sub-Investigator: Dr. Jane Smith
CONSENT FORM The Full Study Title Should Be Placed Here. Principal Investigator: Dr. John Smith Sub-Investigator: Dr. Jane Smith Queen Elizabeth Hospital Queen Elizabeth Hospital 60 Riverside Drive 60
More informationHandout on Expectations, Transitions and Overcoming Imposter Syndrome
Handout on Expectations, Transitions and Overcoming Imposter Syndrome Expectations It is important that we have ideas about the future to provide motivation to engage in the challenges of life and achieve
More informationWhy do Psychologists Perform Research?
PSY 102 1 PSY 102 Understanding and Thinking Critically About Psychological Research Thinking critically about research means knowing the right questions to ask to assess the validity or accuracy of a
More informationAfter Adrenal Cancer Treatment
After Adrenal Cancer Treatment Living as a Cancer Survivor For many people, cancer treatment often raises questions about next steps as a survivor. Lifestyle Changes After Treatment for Adrenal Cancer
More informationRisk communication in dementia care practice
Risk communication in dementia care practice Why is risk communication important? Living with dementia can mean that some individuals are more likely to experience risks in daily life. These may include
More informationThe Current Research on Stretching and Flexibility is Flawed!
Transcript from: https://www.youtube.com/watch?v=qz0ot7tbbg0 Original Article: http://stretchcoach.com/articles/proper-stretching/ The Current Research on Stretching and Flexibility is Flawed! Hi. I'm
More informationAwareness and understanding of dementia in New Zealand
Awareness and understanding of dementia in New Zealand Alzheimers NZ Telephone survey May 2017 Contents Contents... 2 Key findings... 3 Executive summary... 5 1 Methodology... 8 1.1 Background and objectives...
More informationUBC Social Ecological Economic Development Studies (SEEDS) Student Report
UBC Social Ecological Economic Development Studies (SEEDS) Student Report Encouraging UBC students to participate in the 2015 Transit Referendum Ines Lacarne, Iqmal Ikram, Jackie Huang, Rami Kahlon University
More informationWe admitted that we were powerless over alcohol that our lives had become unmanageable.
Step One We admitted that we were powerless over alcohol that our lives had become unmanageable. Alcoholics Anonymous (AA) (2001, p. 59) Before beginning this exercise, please read Step One in Twelve Steps
More informationWe admitted that we were powerless over alcohol that our lives had become unmanageable. Alcoholics Anonymous (AA) (2001, p. 59)
Step One 22 istockphoto.com/qingwa We admitted that we were powerless over alcohol that our lives had become unmanageable. Alcoholics Anonymous (AA) (2001, p. 59) Before beginning this exercise, please
More informationBOLT: Bulls, Owls, Lambs and Tigers -
BOLT: Bulls, Owls, Lambs and Tigers - Looking Through Your Communication Lens A presentation by: Dr. Debbie Phillips, CPM Areas of Exploration Mental Framing & The Power of Intention BOLT Communication
More informationEPF s response to the European Commission s public consultation on the "Summary of Clinical Trial Results for Laypersons"
EPF s response to the European Commission s public consultation on the "Summary of Clinical Trial Results for Laypersons" August 2016 This document received funding under an operating grant from the European
More informationTHE FIRST SESSION CHECKLIST
THE FIRST SESSION CHECKLIST Save time + LOVE your work! F A M I L Y T H E R A P Y B A S I C S. C O M THE FIRST SESSION CHECKLIST CONTENTS 1 INTRODUCTION HOW TO USE THE FIRST SESSION CHECKLIST LET'S CHAT
More informationConsumer Medicine Information TOPICIL. Please read this leaflet carefully before you start using Topicil Capsules.
Clindamycin hydrochloride Capsules 150 mg What is in this leaflet Consumer Medicine Information TOPICIL Please read this leaflet carefully before you start using Topicil Capsules. This leaflet answers
More informationInitial Patient Self Assessment Demographics:
Initial Patient Self Assessment Demographics: Name: Address: E mail: Phone Number: Date of Birth: Gender: Male Female Other Primary Language: English Spanish Other Occupation: Education: Clerical Skilled
More informationWellness along the Cancer Journey: Palliative Care Revised October 2015
Wellness along the Cancer Journey: Palliative Care Revised October 2015 Chapter 3: Addressing Cancer Pain as a part of Palliative Care Palliative Care Rev. 10.8.15 Page 360 Addressing Cancer Pain as Part
More informationDr. Tomasz Beer. Xtandi
In Volume 16 Number 3, Prostate Forum explores XTANDI (enzalutamide) with Dr. Tomasz Beer, the principle investigator in a very important clinical trial about the new drug. Dr. Tomasz Beer Xtandi Dr.Tomasz
More informationChildminder inspection report. Thrussell, Gaynor Livingston
Childminder inspection report Thrussell, Gaynor Livingston Inspection completed on 21 June 2016 Childminder inspection report Service provided by: Gaynor Thrussell Service provider number: SP2006959983
More informationClinical Education Initiative CD4 CD8 CELL RATIOS IN INDIVIDUALS WITH ACUTE AND EARLY HIV INFECTION. Martin Hoenigl, MD
Clinical Education Initiative Support@ceitraining.org CD4 CD8 CELL RATIOS IN INDIVIDUALS WITH ACUTE AND EARLY HIV INFECTION Martin Hoenigl, MD 2/3/2017 CD4 CD8 Cell Ratios in Individuals with Acute and
More informationClass 4: Medicalization
Class 4: Medicalization Sociology of Mental Illness I've got copies of the lecture guide! Extra Credit Anyone bring any? From the syllabus: "You can earn up to five points in extra credit for the final
More informationOffice of Clinical Research. Information for Participants
Office of Clinical Research Information for Participants Research and You Welcome to one of the best health systems in the nation. It is one of the best because as well as highquality, state-of-the-art
More informationA Guide to Reading a Clinical or Research Publication
A Guide to Reading a Clinical or Research Publication For people living with a rare disease, being able to read and understand the information found in a clinical or research publication can be especially
More informationKey Factors and Influencers Impacting the Penile Implant Decision
Key Factors and Influencers Impacting the Penile Implant Decision Christian J. Nelson PhD 1, Cindy Cook BS 2, Lawrence Hakim MD 3, Bud Burnett MD 4, John P. Mulhall MD 1 1 Memorial Sloan Kettering Cancer
More informationThe Who? What? Where? And Why? That the Regulatory Board Member Needs to Know About Foreign-Educated Physical Therapists
This article is based on a presentation by Susan K. Lindeblad, PhD, PT, Managing Director, Foreign Credentialing Commission on Physical Therapy, and Charlotte Martin, MPA, Executive Director, Louisiana
More informationHow to get the most out of your medical appointments. Center For Cardiac Fitness Pulmonary Rehab Program The Miriam Hospital
How to get the most out of your medical appointments Center For Cardiac Fitness Pulmonary Rehab Program The Miriam Hospital Objectives Discuss who works in the typical doctors office Discuss things you
More informationDALES Anaesthetist Survey
1/7 DALES Anaesthetist Survey Thank you for taking part in DALES, a study about drug allergy labels in elective surgical patients. We will ask for your views on some common allergy labels relevant to anaesthetists
More informationWhat is mentalism including some mentalism secrets
What is mentalism including some mentalism secrets Having explained what a mentalist is, it made sense to dig a bit deeper and explain in a bit more detail about what mentalism is. To explain what mentalism
More informationMoving fear into USEFUL anxiety. PACER 12 August 2017 Anne R. Gearity, PhD
Moving fear into USEFUL anxiety PACER 12 August 2017 Anne R. Gearity, PhD Today Examine the connection between fear debilitating anxiety and anxiety that can be useful. Examine ways to restore useful anxiety
More informationCommunity Survey. Preview Copy. Our Community Assessing Social Capital
Our Community Assessing Social Capital Community Survey We are pleased to provide you with this preview copy of our social capital community survey. Our literature search for a community survey was started
More informationEdmonton Symptom Assessment System (ESAS r) Objectives
Edmonton Symptom Assessment System (ESAS r) Lyn Ceronsky DNP, GNP, FPCN lceronsky@gmail.com December 11, 2018 Objectives Explore the use of Edmonton Symptom Assessment System (ESAS r) tool in clinical
More informationSection 4 Decision-making
Decision-making : Experience of health professional communication Conversations about s Participants were asked to describe the conversations they have had about mitochondrial disease options. The most
More informationRoles of Non-HDL Cholesterol in Risk Assessment and Treatment
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/lipid-luminations/roles-of-non-hdl-cholesterol-in-risk-assessment-andtreatment/7066/
More informationRecitation #3. Taking measurements
Recitation #3 Taking measurements Measurement scales Nominal scale Bus #; Gender? Ordinal scale House numbers; Rank in class Interval scale Complex, maybe Grades Ratio scale Heart rate; any measure in
More informationAfter Soft Tissue Sarcoma Treatment
After Soft Tissue Sarcoma Treatment Living as a Cancer Survivor For many people, cancer treatment often raises questions about next steps as a survivor. What Happens After Treatment for Soft Tissue Sarcomas?
More informationChapter 7. M.G.Rajanandh, Department of Pharmacy Practice, SRM College of Pharmacy, SRM University.
Chapter 7 M.G.Rajanandh, Department of Pharmacy Practice, SRM College of Pharmacy, SRM University. Patient counseling is a broad term which describes the process through which health care professionals
More informationFollow-Up Patient Self-Assessment (Version 2)
Follow-Up Patient Self-Assessment (Version 2) Demographics: Name: Address: E-mail: Phone Number: Date of Birth: What is your height? What is your current weight? feet inches lbs Have there been any change(s)
More informationTreatment Approaches for Individuals with Brain Injury. Welcome!
5/10/16 Treatment Approaches for Individuals with Brain Injury www.ndbin.org 855-866-1884 Help for Today, Hope for Tomorrow. Welcome! Todays training is the last in a four part series on brain injury.
More information#032: HOW TO SAY YOU'RE SICK IN ENGLISH
#032: HOW TO SAY YOU'RE SICK IN ENGLISH Hi, everyone! I'm Georgiana, founder of SpeakEnglishPodcast.com. My mission is to help YOU to speak English fluently and confidently. In today's episode: I'll talk
More informationConsumer Perception Survey (Formerly Known as POQI)
Department of Behavioral Health Consumer Perception Survey (Formerly Known as POQI) CPS Comparison May 2017 On a semi-annual basis the County of Fresno, Department of Behavioral Health (DBH) conducts its
More informationMINISTRY OF HEALTH MANATU HAUORA UNDER
MINISTRY OF HEALTH MANATU HAUORA UNDER MINISTRY OF HEALTH MANATu HAUORA Published in June 1999 by the Ministry of Health, Manatū Hauora PO Box 5013, Wellington ISBN 0-478-23548-8 (Booklet) ISBN 0-478-23549-6
More informationPATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Everolimus PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL NAME/STAMP:
More informationINFORMATION AND CONSENT FORM
INFORMATION AND CONSENT FORM A RANDOMIZED CONTROLLED TRIAL TO COMPARE THE IMMUNOGENICITY OF SELF- ADMINISTERED AND NURSE-ADMINISTERED INTRADERMAL INFLUENZA VACCINE Investigators Dr. Shelly McNeil Queen
More informationPATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Carboplatin-Etoposide PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL
More informationMedication Risk/Benefit Communication: What role does disease severity play? Payal Patel. Honors Thesis. Pharmacy Department
Medication Risk/Benefit Communication: What role does disease severity play? Payal Patel Honors Thesis Pharmacy Department UNC Eshelman School of Pharmacy April 13, 2017 Approved: Susan J. Blalock, PhD
More informationAuthor's response to reviews
Author's response to reviews Title:How differently do physicians and patients evaluate the current status of primary care in Korea?: A qualitative study using focus group discussion Authors: Minsu Ock
More informationPatient identifier/label: Page 1 of 7 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM EC-T: EPIRUBICIN / CYCLOPHOSPHAMIDE - DOCETAXEL
Patient identifier/label: Page 1 of 7 PATIENT AGREEMENT TO SYSTEMIC THERAPY: CONSENT FORM EC-T: EPIRUBICIN / CYCLOPHOSPHAMIDE - DOCETAXEL Patient s surname/family name Patient s first names Date of birth
More informationSOCIAL INTERACTION & STRUCTURE. Prof. Jayson M. Barlan, MPA
SOCIAL INTERACTION & STRUCTURE Prof. Jayson M. Barlan, MPA What is social interaction? A process by which people act and react in relation to others. A process whereby people accomplish some aim and is
More informationAppreciating Diversity through Winning Colors. Key Words. comfort zone natural preference
Lesson 2 Appreciating Diversity through Winning Colors Chapter 1 Key Words comfort zone natural preference What You Will Learn to Do Apply an appreciation of diversity to interpersonal situations Linked
More informationHereditary Cancer Syndromes and the Obstetrician/Gynecologist
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/clinicians-roundtable/hereditary-cancer-syndromes-and-theobstetriciangynecologist/6990/
More informationYouth Social Action Survey Wave 2 Topline results
Youth Social Action Survey Wave 2 Topline results The following results are based on 2,021 interviews with young people aged 10-20 years. 2,021 interviews conducted and data processed among young people
More informationPATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Docetaxel-EC PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL NAME/STAMP:
More informationSection 4 Decision-making
Decision-making : Decision-making Summary Conversations about treatments Participants were asked to describe the conversation that they had with the clinician about treatment at diagnosis. The most common
More informationOPIOID PAIN MEDICATION Agreement and Informed Consent
OPIOID PAIN MEDICATION Agreement and Informed Consent I. Introduction Research and clinical experience show that opioid (narcotic) pain medications are helpful for some patients with chronic pain. The
More informationSome of the typical illnesses affecting people with AIDS are tuberculosis (TB), diarrhoea, pneumonia, fungal infections and herpes.
Published on: 27 Nov 2010 Living with Hope Hiv Infection And Its Diagnosis What is HIV? How Does it Cause AIDS? HIV stands for Human Immunodeficiency Virus. It is this virus that causes AIDS or Acquired
More informationPATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Gemcitabine- Carboplatin PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL
More informationLower Back Pain and Irritable Bowel Syndrome
Lower Back Pain and Irritable Bowel Syndrome Written by Scott Best Is there a correlation between lower back pain and Irritable Bowel Syndrome? Researchers have long argued that IBS may be caused by abnormal
More informationThe Ketogenic Man 30 Day Challenge. The Introduction
The Ketogenic Man 30 Day Challenge The Introduction Preface This "diet" (by the end you won't see this as a diet, but more of a lifestyle change), will be like no other diet you've ever been on. The reason
More informationWorkbook Relapse Prevention Name of the patient
Workbook Relapse Prevention Name of the patient The Workbook Relapse Prevention According to research 30-57% of the patients relapse into their eating disorder after having received successful clinical
More informationPATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Irinotecan- Capecitabine (CAPIRI) PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier)
More informationPATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Niraparib PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL NAME/STAMP:
More informationPATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: FEC-P PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL NAME/STAMP: MALE
More informationPATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:
PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY: Nintedanib-Docetaxel PATIENT DETAILS PATIENT S SURNAME/FAMILY NAME: PATIENT S FIRST NAME(S): DATE OF BIRTH: NHS NUMBER: (or other identifier) HOSPITAL
More information5 Quick Tips for Improving Your Emotional Intelligence. and Increasing Your Success in All Areas of Your Life
5 Quick Tips for Improving Your Emotional Intelligence and Increasing Your Success in All Areas of Your Life Table of Contents Self-Awareness... 3 Active Listening... 4 Self-Regulation... 5 Empathy...
More informationEnhancing Regulators Confidence in your Quality Risk Management Work Products
Enhancing Regulators Confidence in your Quality Risk Management Work Products Stephen Reich Quality Systems Director Pfizer Andover PDA New England Meeting Burlington, MA November 14, 2012 Background Today
More information15.301/310, Managerial Psychology Prof. Dan Ariely Recitation 8: T test and ANOVA
15.301/310, Managerial Psychology Prof. Dan Ariely Recitation 8: T test and ANOVA Statistics does all kinds of stuff to describe data Talk about baseball, other useful stuff We can calculate the probability.
More informationTest 1(ch 1 3) sp 06, due 2/9/06. Student: 1. Optimism, trust, and self confidence are components of
Test 1(ch 1 3) sp 06, due 2/9/06 Student: 1. Optimism, trust, and self confidence are components of A. physical wellness. B. emotional wellness. C. spiritual wellness. D. interpersonal wellness. 2. People
More information